|
The Zulf Masters Foundation Silver Anniversary Tour of the Caribbean |
|
Friday, 27 November 2009 |
|
25 years of improving lives in the Caribbean
On December 1st The Zulf Masters Foundation, a charitable organisation set up by Masters Pharmaceuticals' Executive Chairman Dr. Zulf Masters OBE, is setting off on a Silver Anniversary Tour of the Caribbean.
The tour marks the launch of a long-term commitment towards improving the lives of women and children across the Caribbean, and begins in the Cayman Islands on December 1st and covers Bermuda, Jamaica and Trinidad. As part of the tour, Dr. Masters will visit children at local hospitals and organisations to deliver toys, and present donations totaling $60,000 to local charities.
Dr. Masters commented, "The Masters Foundation has been formed with the same principles as Masters Pharmaceuticals, which began in the Caribbean 25 years ago, to facilitate improved care and guidance in easing pain and suffering around the world. The Silver Anniversary Tour will mark a long term commitment towards improving the lives of women and children in the Caribbean."
The tour will visit the Cayman Islands on 1st December, followed by Jamaica (4th December), Trinidad (8th December) and Bermuda (10th December), with each date culminating with a reception, hosted by Dr. Zulf Masters and featuring donations to local charities including the Cayman Islands Cancer Society, St. Mary's Children Home and Bustamante Hospital for Children.
|
|
|
Masters Unveils New Executive Board in Company Restructure |
|
Thursday, 01 October 2009 |
|
Global management structure
Following a strategic review led by Group Chairman Dr Zulf Masters, the following important changes have been made to the group management structure. An executive board has been established which will meet on a quarterly basis, or whenever necessary, to review group strategy, ensure good corporate governance and ensure the shareholders interests are being met.
It will also be charged with reviewing all investment decisions. As part of that process Dr Zulf Masters will now assume the role of Executive Chairman and oversee all board activities, whilst Group Managing Director David Moran, will assume the role of CEO and Paul Weeks will become CFO.
In order to maintain an independent oversight the company is honoured to have Mr Rick Kessler join the board in a non-executive advisory capacity, and it is anticipated that additional members will be added as and when appropriate. Operationally there will be a senior management team reporting into David comprising of the following direct reports:-
General Manager, Central America Guisela Fabian
General Manager, Latin America Cleiton Rabelo
General Manager, Asia Roger Schmid
General Manager, Middle East, Africa Suzad Masters
General Manager, US and Caribbean Bob Zykoski
Business Development Director Nick Rowan
Chief Financial Officer Paul Weeks
Regulatory Affairs Shilpa Gohil / Alex Valdes
|
|
|
Masters Unlock Global Access to Treatment for Rare Parasitic Disease |
|
Sunday, 20 September 2009 |
|
Masters Pharmaceuticals and Lafepe (Pharmaceutical Laboratory of Pernambuco) have this month reached agreement on the global distribution of Benznidazole, a first line treatment for Chagas disease.
Discovered exactly 100 years ago, this disease is endemic across the globe and kills circa 14,000 people each year in Latin America alone. It has become an endemic problem and is neglected by many governments.
Lafepe for their part are one of a very few organisations involved in research into this disease and through the collaboration with Masters aim to make the existing treatment more readily accessible.
David Moran, CEO of Masters, adds “Whilst this treatment is not perfect and will never be a blockbuster, it gives hope to the unfortunate few who are afflicted and we will do all we can to communicate the possibility of treatment wherever the patient maybe.”
Sr. Luciano Vasquez, President of Lafepe, added that he is delighted with the agreement with Masters, which is an integral part of their strategy in the fight against this terrible disease.
|
|
|
Masters Awarded ISO 9001:2000 Certification |
|
Wednesday, 25 February 2009 |
|
Masters International is pleased to announce that the UK office has been awarded the ISO 9001: 2000 certification.
|
|
|
